Skip to content
Upcoming events
AEEDC Dubai 202719–21 January 2027World Health Expo (WHX) Dubai 202725–28 January 2027ChinaDental South China 20273–6 March 2027GermanyIDS 2027 — International Dental Show16–20 March 2027United StatesAAD Annual Meeting 202719–23 March 2027Dubai Derma 20276–8 April 2027Dental-Expo Moscow Spring 202726–29 April 2027France7th World Congress of Dermoscopy12–15 May 2027GermanyEADV Symposium 202720–22 May 2027United StatesASCO Annual Meeting 20274–8 June 2027ChinaSino-Dental 20279–12 June 2027White Nights 2027 — St. Petersburg International Oncology ForumUsually early JulyArmenian Medical World Congress 20278–10 July 2027Dental-Expo Moscow 2027Usually late SeptemberNetherlandsEADV Congress 202722–25 September 2027SpainEAO Congress 202723–25 September 2027CanadaCFAS Annual Meeting 202723–25 September 2027Russian Health Care Week 2027Usually December
Dentistry

Bean-based antiviral chewing gum cut HPV by up to 93% in patient samples, lab study finds

Close-up of a scientist using a pipette in a lab with a focus on sterile procedures.

Key facts

  • A team at the University of Pennsylvania School of Dental Medicine tested extracts of bioengineered chewing gum on saliva and oral rinse samples from patients with head and neck cancer.
  • Extract from gum made with the lablab-bean antiviral protein FRIL reduced HPV by 93% in saliva samples and by 80% in oral rinse samples.
  • A version engineered to carry the antimicrobial peptide protegrin brought two cancer-linked bacteria, Porphyromonas gingivalis and Fusobacterium nucleatum, to almost undetectable levels after a single dose.
  • The extracts did not reduce the beneficial bacteria the researchers examined.

What happened

Henry Daniell and colleagues report the results in Scientific Reports (2026). The work was an ex vivo laboratory study: gum extracts were applied to patient-derived oral samples, and nobody chewed the gum. The team tested one gum containing the plant protein FRIL, which targets viruses, and a second version enriched with protegrin, a peptide that attacks bacteria.

Why it matters

HPV and certain oral bacteria are among the microbes linked to head and neck cancer. A chewing gum is a cheap, non-invasive way to bring an active ingredient into the mouth, so the approach could, in principle, be explored as a way to lower the microbial burden in people at risk.

Context

This is early, laboratory-stage evidence. The university release does not report how many patients or samples were used, and there is no evidence yet that chewing the gum prevents or treats cancer in people. The effects still have to be confirmed in the human mouth in clinical studies.

What it means for clinicians and students

  • Clinicians: no change in practice; HPV vaccination, screening and oral cancer examination remain the established tools.
  • Dental and oral surgery teams: a reminder that the oral microbiome is an active research target in head and neck oncology.
  • Students: a good example of the gap between an ex vivo result and a clinical benefit.

Source: Daniell H, et al. Ex vivo HNSCC clinical studies using saliva and antiviral or antibacterial chewing gums reveal reduction in carcinogenic microbes. Scientific Reports, 2026 (DOI 10.1038/s41598-026-39062-w); University of Pennsylvania School of Dental Medicine, reported by ScienceDaily, 10 November 2026.

Source: ScienceDaily / University of Pennsylvania School of Dental Medicine (Scientific Reports)